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造血細胞移植術と中四国隣帯血バンクの現況








































































































































































































18G 針で採血し， 24 時間以内に処理施設で赤血球除去お
よび凍結処理を行なう。有核細胞だけを分離する方法と
しては，主に hydrox ethyl starch (HES ）を用いて赤
血球を沈降させる方法が採用されている。最終的に凍害






他の総説を参照されたい。 10, 1 ) 
徳島大学のバンクにおいて，平成10 年度に採取・処理
した瞬帯血の量と有核細胞数の分布を示した（図 1, 2 ）。
このように採取臓帯血量の最頻値は70-8ml で， 1. Oxl09 
個以上の細胞が採取できる確率はほとんどなく，仮に





平成10 年 8 月に中四国瞬帯血パンクが設立され，徳島
大学のパンクはその中の採取保存施設のーっとして稼働
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SUMMARY 
The hematopoietic stem cell transplantation (HSCT) is rapidly and widely spreading in 
the treatment strategy of various types of cancers, since peripheral and umbilical cord blood 
(CB) have been introduced as new sources of transplantable cells in addition to ordinary 
bone marrow cells. In this report, the current status of HSCT was reviewed. CB is rich in 
hematopoietic stem/progenitor cells, which have high proliferative potential. T cells in CB 
are speculated to be immature and immune-tolerable cells with less potential to cause acute 
or chronic graft versus host disease (GVHD), which are directly related with transplant-
related morbidity and mortality. Furthermore, transplants with CB are not strictly 
restricted by a HLA-disparity. On the other hand, the less number of collected cells from 
CB is a major problem when the cells are applied for clinical transplantation, because the 
lower number of infused cells often result in engraftment failure. Further, we have no data 
of the viability after long term cryopreservation. We must carefully judge the usefulness of 
CB as a cell source for transplantation, but the benefits of CB may have a possibility to 
overcome these disadvantage in the near future. Finally, the activity of cord blood bank in 
Chugoku-Shikoku area, which was started from August 1998, was also introduced. 
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